Capvaxive
pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein
Centralised EU authorisationActive
Marketing holder: Merck Sharp & Dohme B.V.
Verified 2026-10-09 · EMA
- Source: EMA
Composition
- pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein
Registration
- Registration number
- EMEA/H/C/006267
- Registration status
- Active
- ATC code
- J07AL02
Sources
- product · EMA · EMEA/H/C/006267 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006267 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006267 · Verified 2026-10-09